RxDoctor Payments DataLook up a doctor →

VYVGART HYTRULO: payments to doctors

Payments that named VYVGART HYTRULO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.1M
Providers
7,224
Transactions
34,285
Average per transaction
$91

The per-transaction average — $91 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,224 providers the average total is $430, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Argenx US, Inc.$3,106,935100.0%
← All drugs & devices